Try the modernized ClinicalTrials.gov beta website. Learn more about the modernization effort.
Working…
ClinicalTrials.gov
ClinicalTrials.gov Menu

Comparison of Different Materials Contribution to Implants Stability

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT03501199
Recruitment Status : Completed
First Posted : April 18, 2018
Last Update Posted : March 5, 2019
Sponsor:
Information provided by (Responsible Party):
Gökhan Gürses, Necmettin Erbakan University

Brief Summary:

The investigators will use two types of material(PRF-Xenograft) in the buccal gap after immediate dental implant placement. The study design has three groups PRF, graft, and control group. The patients will randomly be assigned to groups by envelop method. The resonance frequency analysis device(Osstell) will be used to measure primary and secondary stabilization. Then the investigators will evaluate each materials' contribution to stability.

Pre-op and 9th month Post-op CBCTs will evaluate about bone loss in mesial-distal and horizontal dimensions.


Condition or disease Intervention/treatment Phase
Dental Implant Failure Nos Other: platelet-rich fibrin placement Other: xenogenic graft placement Other: no extra material Procedure: tooth extraction Procedure: immediate implant placement Other: collagen membran placement Procedure: raising flap Not Applicable

Layout table for study information
Study Type : Interventional  (Clinical Trial)
Actual Enrollment : 15 participants
Allocation: Randomized
Intervention Model: Parallel Assignment
Masking: Single (Outcomes Assessor)
Primary Purpose: Treatment
Official Title: Comparison of Different Materials Contribution to Immediate Implants Stability With Resonance Frequency Analysis
Actual Study Start Date : March 1, 2018
Actual Primary Completion Date : May 31, 2018
Actual Study Completion Date : March 4, 2019

Arm Intervention/treatment
Experimental: PRF Group
PRF is will be used in immediate dental implant placement.
Other: platelet-rich fibrin placement
filling the buccal gap with platelet-rich fibrin after immediate dental implant placement

Procedure: tooth extraction
extraction of tooth which is unrestorable

Procedure: immediate implant placement
putting dental implant into a socket which has been prepared with compatible drills

Other: collagen membran placement
placing collagen membran on extraction socket after dental implant placement to cover all

Procedure: raising flap
raising the buccal flap with two vertical incision to cover extraction socket for primary closure

Experimental: Graft Group
The xenogenic graft is will be used in immediate dental implant placement.
Other: xenogenic graft placement
filling the buccal gap with xenogenic graft after immediate dental implant placement

Procedure: tooth extraction
extraction of tooth which is unrestorable

Procedure: immediate implant placement
putting dental implant into a socket which has been prepared with compatible drills

Other: collagen membran placement
placing collagen membran on extraction socket after dental implant placement to cover all

Procedure: raising flap
raising the buccal flap with two vertical incision to cover extraction socket for primary closure

Experimental: Control Group
No extra material is will be used in immediate dental implant placement.
Other: no extra material
filling the buccal gap with no material after immediate dental implant placement

Procedure: tooth extraction
extraction of tooth which is unrestorable

Procedure: immediate implant placement
putting dental implant into a socket which has been prepared with compatible drills

Other: collagen membran placement
placing collagen membran on extraction socket after dental implant placement to cover all

Procedure: raising flap
raising the buccal flap with two vertical incision to cover extraction socket for primary closure




Primary Outcome Measures :
  1. Primer Stabilization-Resonance Frequency Analysis [ Time Frame: at 0 day ]
    initial measurement after placement by Osstell device


Secondary Outcome Measures :
  1. Seconder Stabilization-Resonance Frequency Analysis [ Time Frame: 120th day ]
    secondary measurement after placement by Osstell device

  2. Mesial-Distal and Horizontal Bone Loss [ Time Frame: 9th month ]
    The alveolar bone loss between first day to 9th month



Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Layout table for eligibility information
Ages Eligible for Study:   18 Years to 60 Years   (Adult)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   Yes
Criteria

Inclusion Criteria:

  • medically healthy,
  • only one maxillary aesthetic region(incisors or premolars) tooth which has two adjacent teeth is indicated for extraction.
  • intact buccal socket walls
  • the gap between buccal socket wall to implant sholder at least 2 mm.

Exclusion Criteria:

  • relevant tooth has more than one root,
  • smoking,
  • alcohol abuse,
  • pregnancy,
  • immune-suppressive patients,
  • any systemic disease.

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT03501199


Locations
Layout table for location information
Turkey
Necmettin Erbakan University, Faculty of dentistry
Konya, Turkey
Sponsors and Collaborators
Necmettin Erbakan University
Investigators
Layout table for investigator information
Study Chair: Alparslan Esen Consultant
Study Director: Gökhan Gürses Care Provider
Layout table for additonal information
Responsible Party: Gökhan Gürses, Research Assistant, Necmettin Erbakan University
ClinicalTrials.gov Identifier: NCT03501199    
Other Study ID Numbers: NecmettinEU-Dentistry
First Posted: April 18, 2018    Key Record Dates
Last Update Posted: March 5, 2019
Last Verified: December 2018
Individual Participant Data (IPD) Sharing Statement:
Plan to Share IPD: No

Layout table for additional information
Studies a U.S. FDA-regulated Drug Product: No
Studies a U.S. FDA-regulated Device Product: No
Keywords provided by Gökhan Gürses, Necmettin Erbakan University:
immediate implant placement